Despite significant advances, cancer research faces several challenges. Tumor heterogeneity, where cancer cells within the same tumor exhibit different characteristics, complicates treatment. Resistance to therapy, where cancer cells adapt and become less responsive to treatment, remains a major hurdle. Additionally, the high cost of developing new treatments and ensuring equitable access to these therapies are ongoing concerns.
